Modified BuShenYiQi formula alleviates experimental allergic asthma in mice by negative regulation of type 2 innate lymphoid cells and CD4(+) type 9 helper T cells and the VIP-VPAC2 signalling pathway

Huang, MH; Wu, JF; Dong, JC

Dong, JC (corresponding author), Fudan Univ, Huashan Hosp, Dept Integrat Med, 12 Middle Urumqi Rd, Shanghai 200040, Peoples R China.

PHARMACEUTICAL BIOLOGY, 2021; 59 (1): 1216

Abstract

Context Modified BuShenYiQi formula (M-BYF) is derived from BuShenYiQi formula, used for the treatment of allergic asthma. The exact effect and mechan......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索